Vineet Laboratories Ltd (VINEETLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003496, "name": "Vineet Laborator", "stock_name": "Vineet Laborator", "full_name": "Vineet Laboratories Ltd", "name_url": "stocks-analysis/vineet-laborator", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "35.54", "chg": -1.24, "chgp": "-3.37%", "dir": -1, "prev_price": "36.78", "mcapval": "71.00 Cr", "mcap": "Micro Cap", "scripcode": 543298, "symbol": "VINEETLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE505Y01010", "curr_date": "Sep 21, 03:30 PM", "curr_time": "19:36 PM", "last_traded_at": "Sep 21, 03:30 PM IST", "bse_nse_vol": "1.11 lacs", "exc_status": "Active", "traded_date": "Sep 21, 2026", "traded_date_str": "2026 09 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vineet-laborator-1003496-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Vineet Laboratories Ltd Declines 1.38%: Key Valuation Shifts and Market Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-declines-138-key-valuation-shifts-and-market-pressure-4198127", "imagepath": "", "date": "2026-09-19 12:00:44", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Sep:</strong> Vineet Laboratories Ltd hits lower circuit amid heavy selling pressure</p>\n <p><strong>16 Sep:</strong> Valuation shifts signal changing market sentiment</p>\n <p><strong>18 Sep:</strong> Week closes at ₹36.45 (-1.38%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹36.96</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹36.45</div><div class=\"stat-change negative\">-1.38%</div></div>\n <div class=\"stat-item\"><div cla..." }, { "title": "Vineet Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-is-rated-sell-4196333", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_mojoScore_4196333.png", "date": "2026-09-17 10:10:04", "description": "Vineet Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook." }, { "title": "Vineet Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-valuation-shifts-signal-changing-market-sentiment-4193995", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_valuationdot_4193995.png", "date": "2026-09-16 08:01:54", "description": "Vineet Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its current price performance and peer comparisons, suggests a recalibration of price attractiveness for investors within the Pharmaceuticals & Biotechnology sector." }, { "title": "Below All Moving Averages and Now at Lower Circuit: Vineet Laboratories Ltd Loses 3.3% in a Single Session", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4193218", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_stocks_hitting_lower_circuit_4193218.png", "date": "2026-09-15 10:00:31", "description": "At Rs 35.17, sellers were still queuing — but there were no buyers willing to take the other side. Vineet Laboratories Ltd locked at its lower circuit of 5% on 15 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock." }, { "title": "Vineet Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-4190279", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_stocks_hitting_upper_circuit_4190279.png", "date": "2026-09-11 10:00:23", "description": "At Rs 37.57, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vineet Laboratories Ltd locked at its upper circuit of 5% on 11 Sep 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Vineet Laboratories Ltd Locks at Upper Circuit With 0.7% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-4187810", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_stocks_hitting_upper_circuit_4187810.png", "date": "2026-09-09 10:00:28", "description": "At Rs 38.78, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vineet Laboratories Ltd locked at its upper circuit of 5% on 9 Sep 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Vineet Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/vineet-laboratories-ltd-is-rated-sell-4182502", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_mojoScore_4182502.png", "date": "2026-09-04 10:10:05", "description": "Vineet Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 September 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Vineet Laboratories Ltd Locks at Lower Circuit With 3.45% Loss — Sellers Queue, No Buyers in Sight", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4177523", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/VineetLaborator_stocks_hitting_lower_circuit_4177523.png", "date": "2026-09-01 10:00:32", "description": "At Rs 36.92, sellers were still queuing — but there were no buyers willing to take the other side. Vineet Laboratories Ltd locked at its lower circuit of 3.45% on 1 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity." }, { "title": "Vineet Laboratories Ltd Valuation Shifts Signal Expensive Pricing Amid Mixed Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/vineet-laboratories-ltd-valuation-shifts-signal-expensive-pricing-amid-mixed-returns-4170805", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VineetLaborator_valuationdot_4170805.png", "date": "2026-08-27 08:01:32", "description": "Vineet Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an expensive rating. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), comparing them with historical trends and peer averages to assess the stock’s price attractiveness." } ], "total": 324, "sid": "1003496", "stock_news_url": "https://www.marketsmojo.com/news/vineet-laboratories-1003496" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Vineet Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 22", "dt": "2022-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Vineet Laboratories Ltd has announced <strong>13:12</strong> rights issue, ex-date: 23 Dec 25", "dt": "2025-12-23", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

15 Sep: Vineet Laboratories Ltd hits lower circuit amid heavy selling pressure

16 Sep: Valuation shifts signal changing market sentiment

18 Sep: Week closes at ₹36.45 (-1.38%)

Read full news article

Vineet Laboratories Ltd is Rated Sell

2026-09-17 10:10:04

Vineet Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Vineet Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment

2026-09-16 08:01:54

Vineet Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its current price performance and peer comparisons, suggests a recalibration of price attractiveness for investors within the Pharmaceuticals & Biotechnology sector.

Read full news article

Below All Moving Averages and Now at Lower Circuit: Vineet Laboratories Ltd Loses 3.3% in a Single Session

2026-09-15 10:00:31

At Rs 35.17, sellers were still queuing — but there were no buyers willing to take the other side. Vineet Laboratories Ltd locked at its lower circuit of 5% on 15 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock.

Read full news article

Vineet Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-09-11 10:00:23

At Rs 37.57, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vineet Laboratories Ltd locked at its upper circuit of 5% on 11 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Vineet Laboratories Ltd Locks at Upper Circuit With 0.7% Gain — Buyers Queue, Sellers Absent

2026-09-09 10:00:28

At Rs 38.78, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vineet Laboratories Ltd locked at its upper circuit of 5% on 9 Sep 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Vineet Laboratories Ltd is Rated Sell

2026-09-04 10:10:05

Vineet Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 September 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Vineet Laboratories Ltd Locks at Lower Circuit With 3.45% Loss — Sellers Queue, No Buyers in Sight

2026-09-01 10:00:32

At Rs 36.92, sellers were still queuing — but there were no buyers willing to take the other side. Vineet Laboratories Ltd locked at its lower circuit of 3.45% on 1 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Vineet Laboratories Ltd Valuation Shifts Signal Expensive Pricing Amid Mixed Returns

2026-08-27 08:01:32

Vineet Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an expensive rating. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) ratio and price-to-book value (P/BV), comparing them with historical trends and peer averages to assess the stock’s price attractiveness.

Read full news article